Key Areas

Home > Pharmaceutical Innovation > disease areas

Innovative Progress in Our Professional Fields

We pursue a differentiated strategy, with a focus on key therapeutic areas including oncology, anti-infectives, the gastrointestinal system, and the central nervous system (CNS). We are committed to developing products that are highly challenging, first-to-market, or cost-advantaged. At present, we have a pipeline of more than 60 candidates, and since 2018 the company has obtained nearly 50 production approvals, including two Class 1 innovative drugs.

Oncology

Committed to Developing Differentiated Advantageous Products

Explore More

Anti-Infection

Longstanding Commitment with Leading Advantage in Respiratory Infections

Explore More

Gastrointestinal System

We are building high-end technology platforms to provide patients with formulations that have greater clinical value.

Explore More

Central Nervous System

We are the leading provider of the most comprehensive and optimal drug solutions for epilepsy, leading the epilepsy therapeutic sector.

Explore More

You Might Be Interested

Marketed Products

Our innovative drugs are continually providing effective treatment for patients every day, alleviating the impact of their conditions.

Explore more +

R&D Pipeline

As an innovation-driven pharmaceutical company, we are committed to advancing drug discovery and development across key therapeutic areas, including oncology, anti-infectives, the gastrointestinal system, and the central nervous system.

Explore more +

Patient Care

We stand alongside patients in their fight against illness, pursuing innovation with the goal of improving quality of life and delivering meaningful health outcomes.

Explore more +